We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $6.78B
1-Year Est. Return 29.01%
This Fund
S&P 500
This Quarter Est. Return
+22.45%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$424M
AUM Growth
-$63.1M
Cap. Flow
+$663M
Cap. Flow %
156.34%
Top 10 Hldgs %
58.91%
Holding
374
New
118
Increased
27
Reduced
42
Closed
99

Top Buys

Rank Stock Value
1
CRML icon
Critical Metals Corp
CRML
+$13.4M
2
BABA icon
Alibaba
BABA
+$9.27M
3
AMD icon
Advanced Micro Devices
AMD
+$8.53M
4
IBIT icon
iShares Bitcoin Trust
IBIT
+$7.41M
5
FAAS
DigiAsia
FAAS
+$6.7M

Top Sells

Rank Stock Value
1
BFAC
Battery Future Acquisition Corp.
BFAC
+$26.9M
2
GSK icon
GSK
GSK
+$23.7M
3
TSLA icon
Tesla
TSLA
+$20.7M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$16.3M
5
CYTK icon
Cytokinetics
CYTK
+$14.8M

Sector Composition

Rank Sector Weight
1 Financials 18.9%
2 Communication Services 18.51%
3 Technology 14.28%
4 Materials 6.91%
5 Healthcare 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SKGR
126
DELISTED
SK Growth Opportunities Corporation Class A Common Stock
SKGR
$283K 0.07%
+25,600
New +$281K
CTLT
127
DELISTED
CATALENT, INC.
CTLT
$282K 0.07%
+5,000
New +$271K
AUPH icon
128
Aurinia Pharmaceuticals
AUPH
$1.95B
$271K 0.06%
54,033
-91,277
-63% -$619K
BIRK icon
129
Birkenstock
BIRK
$7.64B
$270K 0.06%
5,700
– –
PSTX
130
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$240K 0.06%
75,205
+25,000
+50% +$83.4K
ACAD icon
131
Acadia Pharmaceuticals
ACAD
$4.51B
$238K 0.06%
+12,864
New +$319K
ALNY icon
132
Alnylam Pharmaceuticals
ALNY
$38.3B
$237K 0.06%
+1,584
New +$264K
PM icon
133
Philip Morris
PM
$309B
$232K 0.05%
+2,528
New +$233K
LCW.WS
134
DELISTED
Learn CW Investment Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
LCW.WS
$225K 0.05%
5,000,000
– –
AWK icon
135
American Water Works
AWK
$27B
$222K 0.05%
+1,820
New +$224K
USARW
136
DELISTED
USA Rare Earth Inc Warrant
USARW
$220K 0.05%
1,690,756
– –
ADVM
137
DELISTED
Adverum Biotechnologies
ADVM
$218K 0.05%
15,446
-370
-2% -$5.63K
IVCB
138
DELISTED
Investcorp Europe Acquisition Corp I Class A Ordinary Shares
IVCB
$217K 0.05%
19,344
– –
SPIB icon
139
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$213K 0.05%
6,516
– –
GROY icon
140
Gold Royalty Corp
GROY
$602M
$210K 0.05%
111,578
– –
CB icon
141
Chubb
CB
$140B
$207K 0.05%
+800
New +$197K
RKLB icon
142
Rocket Lab Corp
RKLB
$36.6B
$207K 0.05%
+50,000
New +$231K
CGC
143
PUT
Canopy Growth
CGC
$376M
$182K 0.04%
+142,700
New +$616K
VIEW
144
DELISTED
View, Inc. Class A Common Stock
VIEW
$177K 0.04%
236,372
– –
EVLV icon
145
Evolv Technologies
EVLV
$998M
$163K 0.04%
+40,000
New +$173K
TBPH icon
146
Theravance Biopharma
TBPH
$873M
$161K 0.04%
18,000
– –
OAKU
147
DELISTED
Oak Woods Acquisition Corp
OAKU
$161K 0.04%
+15,000
New +$159K
CHPT icon
148
PUT
ChargePoint
CHPT
$134M
$156K 0.04%
+12,510
New +$491K
LIDR icon
149
AEye
LIDR
$47.2M
$143K 0.03%
114,203
+3
+0% +$4
SLAMW
150
DELISTED
Slam Corp. warrant
SLAMW
$142K 0.03%
674,060
+511,560
+315% +$102K
4 5
6
7 8

Similar funds

JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
CIMLRA
CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $6.75B AUM 8.88% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
SPS
Susquehanna Portfolio Strategies Bala Cynwyd, Pennsylvania $6.73B AUM 45.57% 1-Year Est. Return
BHM
Briar Hall Management Nashville, Tennessee $6.72B AUM 4.95% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

Cantor Fitzgerald's Q1 2024 Portfolio in Review

As of Q1 2024, Cantor Fitzgerald held 374 positions worth $424M, down 13% from $487M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Cantor Fitzgerald deployed $663M of net new capital in Q1 2024, opening 118 new positions and adding to 27 existing holdings. Its largest new stake was Critical Metals Corp: 1,247,250 shares worth $16.7M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 21% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Battery Future Acquisition Corp., an estimated $26.9M trimmed.

  • Cantor Fitzgerald's largest Q1 2024 buy was Critical Metals Corp: 1,247,250 shares worth $16.7M.
  • Cantor Fitzgerald added most to Advanced Micro Devices in Q1 2024, an estimated $8.53M increase.
  • Cantor Fitzgerald's biggest Q1 2024 reduction was Battery Future Acquisition Corp., cutting an estimated $26.9M.
  • Cantor Fitzgerald fully exited GSK in Q1 2024, selling an estimated $23.7M.
  • Cantor Fitzgerald's ten largest holdings make up 59% of its $424M portfolio in Q1 2024.
  • Cantor Fitzgerald opened 118 new positions and closed 99 in Q1 2024.
  • Cantor Fitzgerald's portfolio value fell 13% quarter-over-quarter to $424M.

Based on Cantor Fitzgerald's 13F filing for Q1 2024, filed 15 May 2024.